Skip to main content
OpenTrials
Completed

NCT Number: NCT02248493

Intravenous Paracetamol for Postoperative Pain

The purpose of this study is to define if intravenous paracetamol may improve analgesia and outcome in pediatric surgical patients treated with non-steroidal anti-inflammatory drugs (NSAIDs) postoperatively.

Hypothesis: intravenous paracetamol in a dose 60 mg/kg/24 h IV, given in addition to IV ketoprofen (4,5 mg/kg/24h), improves analgesia and physical recovery in children and adolescents following surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Lithuanian University of Health Sciences Kaunas Clinics

Kaunas, 50009, Lithuania

About this study

Patients aged 1-18 years undergoing general, plastic or orthopedic surgery with expected moderate to severe pain at least for 24 hours postoperatively, who meet inclusion criteria and does not meet exclusion criteria, are enrolled. At the end of surgical procedure, at skin closure, all patients are given 1,5 mg/kg intravenous ketoprofen and repeated every 8 hours up till 4,5 mg/kg/24 h. Patients in paracetamol group are additionally given the first dose of IV paracetamol 20 mg/kg and repeated 6 and 20 hours postoperatively up till 60 mg/kg/24 h. Patients in the placebo group are given 0.9% sodium chloride 2 ml/kg IV and repeated 6 and 20 hours postoperatively.

After surgery optional rescue analgesia is given on patient request: either tramadol in a dose of 2 mg/kg (up till 4 mg/kg/24h), either patient-controlled analgesia (PCA) with morphine, as indicated according to the standard of care. Patients are evaluated up till 24 hours postoperatively. After that patients are followed up as long as indicated per standard of care.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients 1-18 years of age, undergoing general, plastic or orthopedic surgery with expected median to severe pain postoperatively.
  • physical status of the patient corresponding to American Society of Anesthesiologists (ASA) class 1 or 2
  • Signed written informed consent by parents/official caregivers.

Exclusion criteria

  • Allergy to paracetamol, ketoprofen, tramadol, morphine or any NSAID
  • oncologic disease
  • central nervous system disease
  • renal dysfunction
  • hepatic dysfunction
  • bronchial asthma
  • ulcer(s) in gastrointestinal system
  • hemorrhagic diathesis
  • chronic use of NSAIDs
  • chronic use of opioids
  • chronic use of anticoagulants
  • female patient is known to be pregnant

Treatment and study plan

Paracetamol

Drug

Other names: Acetaminophen

Placebo (for paracetamol)

Drug

Other names: 0.9% sodium cloride solution, Normal saline solution, Izotonic saline solution

Ketoprofen

Drug

Other names: Ketonal

Tramadol

Drug

Administered on request as rescue medication in a dose 2 mg/kg IV up till 2 doses. No other opioid is given to these patients.

Other names: Tramal

Morphine

Drug

administered in patients receiving IV PCA with morphine postoperatively. No other opioid is given to these patients.

Primary outcomes

  1. change in postoperative intravenous opioid dose

    Time frame: 24 hours postoperatively

Secondary outcomes

  1. change in pain level (analgesia) assessed by 10 point pain scales

    Time frame: 1 hour postoperatively

  2. change in pain level (analgesia) assessed by 10 point pain scales

    Time frame: 24 hours postoperatively

Other outcomes

  1. time until the first oral intake after surgery

    Time frame: 24 hours postoperatively

  2. time until the first urination after surgery

    Time frame: 24 hours postoperatively

  3. time until ambulation after surgery

    Time frame: 24 hours postoperatively

Sponsors and collaborators

Lead sponsor

Lithuanian University of Health Sciences

Other

Registry information

Official study title

The Effect of Intravenous Paracetamol in Combination With NSAIDs for Postoperative Pain in Children

Acronym: IVPARACET

Important dates

Study start
2012
Primary completion
2017
Study completion
2017
First posted
Sep 25, 2014
Registry last updated
Mar 6, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.